dc.contributor.author |
Orang’o, Elkanah Omenge |
|
dc.contributor.author |
Bocage, Anne E. |
|
dc.contributor.author |
Liu, Tao D. |
|
dc.contributor.author |
Itsura, Peter M. |
|
dc.contributor.author |
Tonui, Philip K. |
|
dc.contributor.author |
Muthoka, Kapten |
|
dc.contributor.author |
Stephen, Kiptoo |
|
dc.contributor.author |
Caliendo, Angela M |
|
dc.contributor.author |
Sam, Soya S |
|
dc.contributor.author |
Cu-Uvin, Susan |
|
dc.date.accessioned |
2023-02-03T12:17:20Z |
|
dc.date.available |
2023-02-03T12:17:20Z |
|
dc.date.issued |
2022-12-16 |
|
dc.identifier.uri |
https://doi.org/10.1093/ofid/ofac662 |
|
dc.identifier.uri |
http://ir.mu.ac.ke:8080/jspui/handle/123456789/7249 |
|
dc.description.abstract |
This prospective study of 39 women living with human
immunodeficiency virus (HIV) on antiretroviral therapy in
Western Kenya aimed to quantify genital tract HIV-1 RNA
(GT-HIV RNA) shedding before and after cryotherapy for
cervical intraepithelial neoplasia. Most GT-HIV RNA
shedding was detected precryotherapy, suggesting that
cryotherapy was not the primary cause of shedding. |
en_US |
dc.description.sponsorship |
5P30AI042853) |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Oxford University Press |
en_US |
dc.subject |
Cervical cancer |
en_US |
dc.subject |
Cervical cancer treatment; |
en_US |
dc.subject |
Cryotherapy |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
HIV genital tract viral load |
en_US |
dc.title |
Human immunodeficiency virus Type 1 RNA genital tractshedding after cryotherapy for cervicalintraepithelial neoplasia in Western Kenya |
en_US |
dc.type |
Article |
en_US |